{
  "symbol": "MRM",
  "company_name": "Medirom Healthcare Technologies Inc ADR",
  "ir_website": "https://medirom.co.jp/en/ir",
  "structured_data": [
    {
      "section_name": "Presentation Document",
      "links": [
        {
          "title": "Download",
          "url": "https://medirom.co.jp/upload/tenant_1/Medirom Investor Presentation.pdf",
          "content": "NASDAQ: MRM\nSeptember, 2023\nImportant Notices\nIMPORTANT NOTICES AND DISCLAIMERS\nThis investor presentation (this “Investor Presentation”) is for informational purposes only and does not constitute an offer tosell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other securities of MEDIROM Healthcare Technologies\nInc., a company organized under the laws of Japan (the “Company,” “we,” “us” or “our”). The information contained herein does not purport to be all inclusive. The data contained herein is derived from various internal and external sources believed to be reliable, but there\ncan be no assurance as to the accuracy or completeness of such information. Any data on past performance contained herein is not an indication as to future performance. Except as required by applicable law, the Company assumes no obligation to update the\n.\nC information in this Investor Presentation. Nothing herein shall be deemed to constitute investment, legal, tax, financial, accounting or other advice. The communication of this Investor Presentation is restricted by law, and it is not intended for distribution to, or use by any\nN person in, any jurisdiction where such distribution or use would be contrary to local law or regulation. No representation or warranty (whether express or implied) has been made by the Company with respect to the matters set forth in this Investor Presentation.\nI\nS Forward Looking Statements\nE\nI\nG Certain statements included in this Investor Presentation are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may\nO include projections and estimates concerning our possible or assumed future results of operations, financial condition, businessstrategies and plans, market opportunity, competitive position, industry environment, and potential growth opportunities. In some cases, you\nL can identify forward-looking statements by terms such as \"may,\" \"will,\" \"should,\" \"design,\" \"target,\" \"aim,\" \"expect,\" \"could,\" \"intend,\" \"plan,\" \"anticipate,\" \"estimate,\" \"believe,\" \"continue,\" \"predict,\" \"project,\" \"potential,\" \"goal\" or other words that convey the uncertainty of\nO future events or outcomes. You can also identify forward-looking statements by discussions of strategy, plans or intentions. These forward-looking statements include, but are not limited to, statements regarding future revenue, Adjusted EBITDA, Adjusted EBITDA\nN Margin, debt, capital expenditure and cash flow estimates and forecasts of other financial and performance metrics (including key performance indicators), and projections of market size and opportunity. These statements are based on various assumptions and on the\ncurrent expectations of the Company and its management and are not predictions of actual performance. While our management considers these assumptions and expectations to be reasonable, they are inherently subject to significant business, economic, competitive,\nH\nregulatory and other risks, contingencies and uncertainties, including continuing impact of the COVID-19 pandemic, and other risks, most of which are difficult to predict and many of which are beyond our control. If the risks materialize or our assumptions prove\nC\nincorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the\nE\nT forward-looking statements. In addition, forward looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this Investor Presentation. The Company anticipates that subsequent events and developments will\ncause these assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon\nE\nas representing the Company's assessments as of any date subsequent to the date of this Investor Presentation.\nR\nA\nC Market and Industry Data\nH\nT This Investor Presentation contains references to industry market data and certain industry forecasts. Industry market data and industry forecasts are obtained from publicly available information and industry publications. Industry publications generally state that the\nL information contained therein has been obtained from sources believed to be reliable, but that the accuracy and completeness of that information is not guaranteed. Although we believe industry information to be accurate, it is not independently verified by us. Some\nA data is also based on our good faith estimates, which are derived from our review of internal surveys or data, as welIas the independent sources referenced above. Assumptions and estimates of our and our industry's future performance are necessarily subject to a high\nE\ndegree of uncertainty and risk due to a variety of factors. These and other factors could cause future performance to differ materially from our assumptions and estimates.\nH\nM Non-GAAP Financial Measures\nO\nThis Investor Presentation includes key performance indicators and non-GAAP financial metrics that we use to help us evaluate our business, identify trends affecting our business, formulate business plans, and make strategic decisions. Adjusted EBITDA andAdjusted\nR\nEBITDA Margin are financial measures that are calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles in the United States of America (\"GAAP\"). Any non-GAAP financial measures used in this\nI\nD Investor Presentation are in addition to, and not meant to be considered superior to, or a substitute for, the Company's financial statements prepared in accordance with GAAP. A reconciliation of each of these non-GAAP measures to their nearest GAAP measure is set\nE forth in page 28 of this Investor Presentation.\nM\nThe Company believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. The Company's management uses\nthese non-GAAP measures to compare our performance to that of prior periods for trend analyses and for budgeting and planning purposes. These measures are used in monthly financial reports prepared for management and our board of directors. We believe that\nthe use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends in and in com paring our financial measures with other similar companies, many of which present similar non-GAAP financial\nmeasures to investors. Management does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant\nexpenses and income that are required by GAAP to be recorded in our financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in\ndetermining these non-GAAP financial measures. Undue reliance should not be placed on these measures as the Company's only measures of operating performance, nor should such measures be considered in isolation from, or as a substitute for, financial information\npresented in compliance with GAAP. Non-GAAP financial measures as used in respect of the Company may not be comparable to similarly titled amounts used by other companies.\nAdditional information with respect to the Company is contained in its filings with the SEC and is available at the SEC's website, http://www.sec.gov, and on the Company's website, https://medirom.co.jp/en/.\n2\nProducts\n事業紹介\nand Services\nソフトウェア事業\nリラクゼーション事業 ハードウェア事業\nSoftware\nRelaxation Salon Hardware\nチャットで生活習慣改善を\n「Re.Ra.Ku」を中心に国内 世界初！24時間365日充電不\n特定保健指導を中心に支援。\nlaunched 2019\nで312店舗を運営。 要の活動量計を開発。\nstarted 2003 released 2020\n（2023年1月末時点）\n3\nCompany Highlights\nWellness Salon Business\n➢ Re.Ra.Ku®\n.\nC • Over 312 stores throughout Japan (December 31, 2022)\nN\nI • Directly-owned salons –199 salons (December 31, 2022)\nS\nE • Franchise salons – 113 salons (December 31, 2022)\nI\nG\n• Winner of several industry awards in Japan\nO\nL\nO\nN ➢ ZACC\nH\n• High-end hair salon company recognized in the beauty industry for more than 30 years\nC\nE\nfor its high level of professional skills, customer-oriented services, and brand recognition\nT\nE • Acquired 60% of the ownership interest in ZACC in October 2021 and subsequently\nR\nA\nacquired the remaining 40% in January 2022\nC\nH\nT\nL\nA\nE Digital Preventative Healthcare Technology\nH\nM\nO\n➢ MOTHER Bracelet®\nR\nI • Health monitoring wearable device “Mother Bracelet” was launched in 2022.\nD\nE\n• MOTHER Bracelet™ fitness device is designed to track and collect the health data of the\nM\nwearer, such as calorie consumption, activity and sleep patterns\n➢ Lav®\n• Medirom’s internally developed on-demand health monitoring smartphone application\n• Remote weight loss program with ties to benefits from government insurance programs\n• Digital platform that connects individuals with healthcare professionals\n4\nExtensive vocationsl Facilities & Partnerships\nWe Have Established One Of The Largest Educational Schools In Japan\nRe.Ra.Ku® therapists support customers in our salons and after their appointments through health management\n. •\nC\nN\ntailored for each customer.\nI\nS\nProvide over 120 in-depth curriculums that range from techniques to salon management.\nE •\nI\nG\nTeach not only relaxation customer services but also LAV app services.\nO •\nL\nO • Professional lecturers that specialize in their area of expertise.\nN\nH\nC SPA\nCOMMERCIAL\nSTAND ALONE\nE\nFACILITIES\nT COMPLEX\nSALONS\nE\nR\nA\nC\nH\nT\nL\nA\nE\nH\nM\nO\nR\nI\nD\nE\nM\nHigher repeat ration and unit sales\nStrong affinity between bodywork and Only major companies can enter the\nLocal community-based\nspa facilities. market.\nLoyal Customer Base\nEntry Barrier High Entry Barrier\nBrand Recognition\nValue Added Services Value Added Services\nHigher Sales per Customer Consistent with our Dominant Strategy in\nNew bathing facilities in the Kanto region Metropolitan Area\nare increasing\n5\nMEDIROM History\n.\nC\nStarting Device\nN\nI Business\nS\nE\nI\nG Development of Self-\nO Acquired\nFoundation Opening Salons at Charging Health\nAcquired Mother\nL\nMonitoring Tracker ZACC K.K.\nO\nSAWAN Co.LTD. Gateway\nSpa Facilities\nN CEO & Founder (Hair Salons)\n(MOTHER Bracelet™, under\nH\nKouji EGUCHI development)\nC\nE\nT\nE\nR\nA\nC\nH\n2000 2017 2018 2020 2021 2022 2023\nT\nL\nA\nE\nH\nM\nO IPO in Dec 2020\nLaunched MHR: 312 Salons\nR REMONEY\nI Latest Opened\nD\nTherapist Dispatch Closed $12m American\nE Salon\n365 Days Health\nM Business Depositary Shares\nSpa Re.Ra.Ku®\nMonitoring\nOffering\n* # Salons as of December 31, 2021\n(MHR: MEDIROM Human Resources Inc.)\nLaunch of On-demand\nHealth Coaching App\n(Lav®) May 2019\n6\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nWellness Salon Business\nT\nE\nR\nA PROVIDING THE HIGH QUALITY, INNOVATIVE PREVENTIVE SOLUTIONS\nC\nH\nT\nL\nA\nE\nH\nM\nO\nR\nI\nD\nE\nM\n7\nRelaxation Salons & Hair Salon Component:\nBusiness Snapshot\n80%+ in 2022\nBodywork Excellence\nHigh Repeat Customer Ratio\nHolistic and preventative healthcare services\n▪\n.\nC\nN Recognized therapist training platform\n▪\nI\nFocus on High Density Areas\nS\nE\nI Specialty\nG\nO Retail metros/subways, malls, plazas\nL\nO • Focus on a shoulder blade body work Major cites (Tokyo, Nagoya, Osaka)\nN\nH\nWeight loss body work\nC •\n$62/customer in 2022 vs. the industry\nE\nT\nE standard of ~$56*\nR\nBrands\nA\nC\nH\nReRaKu & ReRaKu Spa & Bell Epoc: Standard body works\nT •\nL 826K\nA\nE\nReRaKu Pro: For athlete\nH •\nServed 826,231 customers in 2022\nM\nO\nRecurring Fee Model\nR\nI\nD\nE\nRoyalty fees, monthly education fees,\nM ▪\nmanagement fees and system fees from\nFranchise salon owners. Franchise salon owners\nare contracted to use our services.\nAcquisition of ZACC Hair Salons\nFurther, to support the opening of new ZACC brand salons by sharing the\n▪\nCompany's expertise in franchising, employee independence programs, etc.\n*Yano Research Institute Ltd, 2022.8\nSalon Growth Strategy\nConversion of Directly-Operated Salons to a Store Investment Model\n• As of December, 2022 we have entered into Salon Sales Agreements to sell 28 previously directly operated salons. .\n.\nC\nN\n• The Company believes this model will maximize the return on capital investment in its relaxation salon segment.\nI\nS\nE\nI\nG\nO\nL\nO Acquisition of Relaxation Salons/Competitors\nN\nH\nC • Already succefully acquired three competitors/relaxation salon brands: Joyhands , Bellepoc and Sawan.\nE\nT\nE • We are one of the top three companies, on a consolidated basis, in the Kanto region, in terms of the number of salons.*\nR\nA\nC\nH\nT\nL Vocational Training Facilities\nA\nE\nH\n• Teaching bodywork techniques, customer services, and LAV app treatment.\nM\nO\nR • Use well trained therapists as LAV app coach. That saves coach resource expenses.\nI\nD\nE\nM • Controllable and well managed therapists keep good quality services both salon and LAV coaching app.\n9\n*Source: 2019 industry report by Yano Research Institute Ltd.\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN Digital Preventative\nH\nC\nE\nT Healthcare Technology\nE\nR\nA\nC\nH INFORMATION AND COMMUNICATION TECHNOLOGY (ICT)\nT\nSOLUTION WITH APP, WEARABLE & RE.RA.KU® TRAINED\nL\nA\nTHERAPISTS\nE\nH\nM\nO\nR\nI\nD\nE\nM\n10\nDigital Preventative Healthcare Technology:\nMOTHER Bracelet™\nSELF-CHARGING FITNESS TRACKER “MOTHER BRACELET™” UNDER CO-DEVELOPMENT WITH MATRIX INDUSTRIES, INC.\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nT\nE\nR\nA\nC\nH\nT\nL\nA\nE TECHNOLOGY FEATURE-RICH & USER FRIENDLY TARGET MARKET\nH\nM\nO • MATRIX’s Patented Technologies • Pedometer • Hospitals, Nursing Homes and Gyms\nR\nI\nD\nE • Thermoelectric Module & Boost • Fitness Tracking • Logistics and Transportation Industry\nM\nConverter (Drivers’ Health Monitoring Needs)\nPulse and Body Temperature\n•\nRetail Sale with Crowd-Funding\nSleep Pattern •\n•\nSDK (Software Development Kit)\n•\nOpen to Third Parties\n•\nWaterproof\n•\n11\nInnovative Fitness Tracker that does not\nRequire Recharging\n.\nC\nWe believe our Mother Bracelet is the only fitness tracker that requires no\nN\nI\nelectric charging as it utilizes innovative technology\nS\nE\nI\nG\nThermoelectric generation and combined with Solar power generation\nO\nL\nO\ncombo: a thermoelectric generator converts temperature differences\nN\nH\nC\ndirectly into electrical energy. In other words, it is recharged just by being\nE\nT\nE\nR worn. Continuous 24/7 health data tracking.\nA\nC\nH\nT\nL\nA\nE Providing SDKs for more flexible data linkage\nH\nM\nO\nIn addition to common API integration, the MOTHER-SDK enables direct\nR\nI\nD\nE linking and transferring data from each MOTHER Bracelet to corporate’s\nM\nown applications & database.\nSuggested Retail Price：USD399\n• Water Resistance\n• Gyroscope\n• PPG Heart rate sensor\n• Temperature sensor\n• LED & Vibration Motor\n12\nThree Reasons for being Recharge-Free\nEmpowered With Innovative Thermoelectric Generator\n.\nC\nExclusive utilization of the thermoelectric power generation technology\nN\nI\nS developed by Matrix Industries, Inc. in the United States (Silicon Valley).\nE\nI\nG\nThe temperature difference between the body skin and the outside air\nO\nL\nO enables constant power generation.\nN\nH\nC Combined With Solar Power Generator\nE\nT\nE\nR\nMounted with a TDK's PV (Solar Panel) on the surface, which\nA\nC\nH mutually complements thermoelectric power generation. It enables\nT\nL\nA an alternative charging in environments with little temperature\nE\nH\ndifference. Power generation even by indoor lighting (200Lx~).\nM\nO\nR\nHigh Performance At Low Power\nI\nD\nE\nM\nUnique algorithm that maximizes performance as an\nsmart health tracker with minimum power consumption.\n13\nRequired Equipment for Installation\nMonthly fee\n. MOTHER Bracelet\nC\nN\nI\nS\nE\nSuggested Monthly Fee\nI\nG\nO • Enables 24-hour monitoring\nL\nO $9.99*\nN\n• Solving the problem of running out of battery charge to the\nH\nC\nE\nnursing care market\nT MOTHER System\nE\nR\nA • One unit is required to watch over one preson\nC\nH\nT\nL\nA\nE\nH\nM MOTHER Gateway\nO\nR\nI\nD\nE\nM\n• MOTHER Bracelet is automatically acquired via Bluetooth\n• Up to 5 units can be paired\n• The acquired data is centrally managed by the operator on the\n※Includes Gateway\nREMONEY system\nLTE communication fees, server\nusage fees (held for one month), and other\nadministrative fees. 14\nAdministration Dashboard\nREMONEY Management Screen With Alert Function\nMother Bracelet > Mother gateway > REMONEY\n.\nC\nN\n❶Reliable Alert Notification\nI\nS\nE\nI\nG\nFall Detection & Heart Rate Alert via System Dashboard: for\nO\nL accidents prevention and rapid response in case of the\nO\nN emergency.\nH\nC\nE\nT\nE\nR\nA\nC ❷SOS Notification\nH （supported by the end of 2023）\nT\nL\nAccident prevention and prompt medical response by\nA\nE\nH directly detecting the SOS call sent by a user\nM\nhimself/herself.\nO\nR\nI\nD\nE\nM\n❸Customized Dashboard\nPossibility to develop a personalized management\ndashboard that meets client’s requirements and is tailored\nto the specific needs.\n15\n24 Hours x 365 Days Health Monitoring: Introduction In\nVarious Sectors\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nT\nE\nR\nA\nC Drivers’ Health Status Real-\nH\nPhysician Rounds\nT\nTime Monitoring\nL\nA\nE\nH\nManaged by the designated\nM\nO\nR administrator\nI\nD\nCentralized\nE\nM\nMonitoring\nSystem\nNursing Rounds/ Clinical Trials Progress/\nTemperature Checks Real-Time Monitoring\n〜And many other inquiries from various businesses\n16\nWearable Device Features Comparison & Market*\nBrands A O MOTHER\n.\nC\nN Style Watch Ring Bracelet\nI\nS\nE\nI\nG Continuous Use w/o recharge Within 1 Day 4-7 Days Unlimited\nO\nL\nO\nN\nSleep ⚫ ⚫ ⚫\nH\nC\nE\nT\nHeart Rate ⚫ ⚫ ⚫\nE\nR\nA\nC\nH Steps Count ⚫ ⚫ ⚫\nT\nL\nA\nE\nActivity（Calories） ⚫ ⚫ ⚫\nH\nM\nO\nSurface Body Temperature ⚫ ⚫ ⚫\nR\nI\nD\nE\nM\nWaterproof ⚫ ⚫ ⚫\nNFC FeliCa --- Mifire\n*Source: IDC Market Forecast –Worldwide Quarterly Wearable Device Tracker\n17\nhttps://www.idc.com/getdoc.jsp?containerId=prJPJ47221920\nDigital Preventative Healthcare Technology:\nCoaching App “Lav®”\nREMOTE WEIGHT LOSS PROGRAM WITH TIES TO BENEFITS FROM GOVERNMENT INSURANCE PROGRAMS\n.\nC Activities, Sleep, Weight Wearable Device User Growth\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nT\nE\nR\nA\nC\nH\nT\nL\nA\nE\nH\nM\nO On-Demand Training Client Growth\nR\nI\nD\nE\nM\nReceive\nFeedback\nTwice A\nfrom Coach\nWeek\nInternal and External\n(Contractors) Nutritians /\nDietitians\n18\n*In August 2020, we started releasing “Lav®” application directly to consumers.\nDigital Preventative Healthcare Technology:\nSpecific Health Guidance Business\nEngaged partners include blue chip\nGOVERNMENT SUPPORTED HEALTH GUIDANCE PROGRAM corporations and governmental bodies\n.\nC\nN\nI\nFUJITSU GENERAL JAPAN\nS Government\nE\nI\nG\nO\nL DAIKIN\nO\nN\nH\nC\nE KOKUYO\nT\nE\nR\nA\nC\nH\nT\nL\nA\nE\nH Future growth\nService Provider Company Health Insurance Providers\nM\nAcquire health check up companies\nO\nR\nI\nD\nHealth Insurance\nE\nM\nProviders\nInsured Persons\n*For Illustrative purposes\n19\nHealthcare Technology Growth Strategy\nAll in One Package (Mother Bracelet, Mother Gateway and REMONEY)\n.\nC\nN\nI\nS\n• Focus on the 3M drivers and 10M patients in Japan.\nE\nI\nG\n• Partnership with strong and well trusted sales companies.\nO\nL\n• Potential expansion to global market.\nO\nN\nH\nC\nE\nT\nE\nR\nA\nC\nH\nT\nL\nA Specific Health Guidance Business with Coaching App “Lav®”\nE\nH\nM\nO • Focus on 30M patients with lifestyle related disease, such as (Diabetes, High blood pressure and heart failure.)\nR\nI • Target the hospital, nursing homes and health check up companies and install the LAV solutions.\nD\nE\nM • Potential with the Fortune 500 and health well being companies in Japan.\n20\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nFinancial Highlights\nT\nE\nR\nA COMPANY YEAR END: DECEMBER 31\nC\nH\nT\nL\nA\nE\nH\nM\nO\nR\nI\nD\nE\nM\nIncome Statement\nRevenue EBITDA\n.\nC\nN\nI\nS\nE $3\n$2.6\n$60\nI\nG\nO\nL D $52.7 $2\nO\nS\nN U $1.2\n$50\nH n\nC i $45.0 $1\ns\nE n\nT o\ni\nE l l $0\nR i $40\nM\nA\n$35.2 2019 2020 2021 2022\nC\nH -$1\n-$0.7\nT $30.1\nL\nA $30\nE -$2\nH\nM\nO -$3\n$20\nR\nI\nD\nE -$4\nM\n$10\n-$5\n-$4.8\n-$6\n$0\n2019 2020 2021 2022\nOur functional currency and reporting currency is the Japanese yen (which we refer to as “JPY” or“¥”). The terms “dollar,” “USD,” “US$” or “$” refer to U.S. dollars, the legal currency of the United States. Convenience translations included\nin this annual report of Japanese yen into U.S. dollars have been made at the exchange rate of ¥131.810 = US$1.00, which was the foreign exchange rate on December 30, 2022 as reported by the Board of Governors of the Federal\nReserve System\n22\n(1) For a reconciliation of Adjusted EBITDA to net loss, the most comparable U.S. GAAP measure, see the following page.\n(2) Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA for a period by total revenue for the same period.\nReconciliation of Adjusted EBITDA\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nT\nE\nR\nA\nC\nH\nT\nL\nA\nE\nH\nM\nO\nR\nI\nD\nE\nM\nOur functional currency and reporting currency is the Japanese yen (which we refer to as “JPY” or“¥”). The terms “dollar,” “USD,” “US$” or “$” refer to U.S. dollars, the legal currency of the United States. Convenience translations included\nin this annual report of Japanese yen into U.S. dollars have been made at the exchange rate of ¥131.810 = US$1.00, which was the foreign exchange rate on December 30, 2022 as reported by the Board of Governors of the Federal\nReserve System\n23\nCapitalization\n.\nC\nData as of 8/11/2023\nN\nI\nS\nE\nI\nG\nO Market Cap USD $30.7 million\nL\nO\nN\nH\nC\nE\nStock Price | 52-Week Range* $6.30 | $4.01 - $7.40\nT\nE\nR\nA\nC\nH\nT Basic Shares Outstanding 4.88 million\nL\nA\nE\nH\nM\nO\nManagement Ownership 39.65%\nR\nI\nD\nE\nM\n* Represent the market price of the American Depositary Shares, each representing one common share.\n24\nKey Management Team and Board\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nT\nE\nR\nA\nC\nH\nT\nL\nKouji Eguchi Fumitoshi Fujiwara Tomoya Ogawa Akira Nojima\nA\nE\nH Founder, CEO and Director CFO and Director Outside Director Outside Director\nM\nO 1996 Joined Jack Co.,\nR 1999 Served as executive managing director at 2000 Executive Officer and CFO in Spiral Star Co., Ltd. 1997 Recruit Co., Ltd\n2007 Abe, Ikubo & Katayama Law Firm\nI\nD Pricedown.com, Inc. 2002 Established AC Capital, Inc. 2014 Director of Academy of Beauty Business\n2010 General manager at DeNA Inc.\nE 2000 Established Reraku Representative Director Managing Partner 2020 Independent director & board of directors\n2012 Director of Akatsuki Inc.\nM\n(current MEDIROM Healthcare Technologies Inc.) 2009 Established Eaglestone Capital Management Inc.\n2014 Independent director & board of directors\nBecame Representative Director (present post). Representative Director Management Partner (present post).\n2010 Director of the Association of Japan 2017 Executive officer in MEDIROM Healthcare Technologies Inc.\nRelaxation Industry (present post).\n25\nInvestment Highlights\nAccretive M&A with Low-Hanging Fruit – Proven Track Record of M&A\n• Targeting M&A opportunities with both direct and indirect financing (not hostile mergers) with strategy of full integration of\ncorporate functions (back-office operations etc.).\n. C • Located in Japan, MEDIROM is the first publicly listed Japanese company in the industry.\nN\n• MEDIROM intends to leverage its experience from successful M&A historical acquisition.\nI\nS\nE\nI\nG\nO\nL\nO\nExtensive Education Facilities\nN\nH\n• Operate one of the largest vocational schools in Japan.\nC\nE\n• Teach bodywork techniques, customer services, and LAV app treatment.\nT\nE\nR\nA\nC\nH\nFurther Enhance Relationships & Capabilities\nT\nL • Government-sponsored Specific Health Guidance Program.\nA\nE • Engaged partners include blue chip corporations and governmental bodies for LAV.\nH\n• MOTHER Patient Monitoring System for Health Care Facilities.\nM\nO\nR\nI\nD\nTechnological Advancement\nE\nM\n• Experienced engineers for Apps, back-end server, AWS.\n• Telemedicine System. Develop efficient core chat system.\n• MATRIX’s Patented Technologies: Thermoelectric Module & Boost Converter.\n26\nNASDAQ: MRM\nSeptember, 2023\nThank You!\nMEDIROM Healthcare Technologies Inc.\n2-3-1, Daiba, Minato-ku,\nTokyo, JAPAN 135-0091\nir@medirom.co.jp\nwww.medirom.co.jp/en/ir\n.\nC\nN\nI\nS\nE\nI\nG\nO\nL\nO\nN\nH\nC\nE\nAppendix\nT\nE\nR\nA FOR ADDITIONAL INFORMATION\nC\nH\nT\nL\nA\nE\nH\nM\nO\nR\nI\nD\nE\nM"
        }
      ]
    },
    {
      "section_name": "Financial Data",
      "links": [
        {
          "title": "Income Statement (2023) Excel",
          "url": "https://medirom.co.jp/upload/tenant_1/MRMIncomeStatement2023.xlsx",
          "content": null
        },
        {
          "title": "Income Statement (2023) PDF",
          "url": "https://medirom.co.jp/upload/tenant_1/MRMIncomeStatement2023.pdf",
          "content": "FS_IncomeStatement\nYears Ended December 31,\n2023 2022\nRevenues:\nRevenue from directly-operated salons ¥ 5,656,519 ¥ 5,396,294 ¥\nFranchise revenue 971,027 1,163,998\nOther revenues 200,397 393,765\nTotal revenues 6,827,943 6,954,057\nCost of revenues and operating expenses:\nCost of revenue from directly-operated salons 4,552,408 4,129,240\nCost of franchise revenue 523,330 645,733\nCost of other revenues 183,337 276,627\nSelling, general and administrative expenses 1,960,447 1,805,490\nImpairment loss on long-lived assets ― ―\nTotal cost of revenues and operating expenses 7,219,522 6,857,090\nOperating income (loss) -391,579 96,967\nOther income (expense):\nDividend income 2 2\nInterest income 1,111 6,072\nInterest expense -36,868 -9,800\nGain from sales of salons 413,678 ―\nSubsidies 21,376 20,625\nForeign exchange income 26,825 14,830\nOther, net -13,923 51,078\nTotal other (expense) income 412,201 82,807\nIncome (loss) before income tax expense 20,622 179,774\nIncome tax (benefit) expense -94,427 30,809\nNet income (loss) 115,049 148,965\nLess: Net loss attributable to noncontrolling interests -355 ―\nNet income (loss) attributable to shareholders of the Company ¥ 115,404 ¥ 148,965 ¥\nNet earnings (loss) per share attributable to shareholders of the Company\nBasic ¥ 23.64 ¥ 30.54 ¥\nDiluted ¥ 22.34 ¥ 27.23 ¥\nWeighted average shares outstanding\nBasic 4,882,501 4,877,405\nDiluted 5,166,653 5,470,655\nYears Ended December 31,\n2021\n4,006,834\n1,359,026\n43,965\n5,409,825\n3,281,781\n691,286\n21,347\n1,822,787\n63,211\n5,880,412\n-470,587\n2\n839\n-11,950\n―\n27,846\n14,992\n24,377\n56,106\n-414,481\n576,250\n-990,731\n―\n-990,731\n-203.13\n-203.13\n4,877,405\n4,877,405"
        },
        {
          "title": "Balance Sheet (2023) Excel",
          "url": "https://medirom.co.jp/upload/tenant_1/MRMBalanceSheet2023.xlsx",
          "content": null
        },
        {
          "title": "Balance Sheet (2023) PDF",
          "url": "https://medirom.co.jp/upload/tenant_1/MRMBalanceSheet2023.pdf",
          "content": "FS_BalanceSheets\nDecember 31,\n2023 2022 2021\nASSETS\nCurrent assets:\nCash and cash equivalents ¥ 106,347 ¥ 605,454 370,617\nTime deposits 26,502 26,500 26,526\nAccounts receivable-trade, net 621,867 534,686 312,302\nAccounts receivable-other, net 606,074 789,819 542,988\nInventories 139,982 114,109 18,703\nPrepaid expenses and other current assets 257,932 292,643 111,166\nTotal current assets 1,758,704 2,363,211 1,382,302\nProperty and equipment, net 451,498 424,288 424,996\nGoodwill 484,564 539,490 600,329\nOther intangible assets, net 920,700 403,674 391,038\nInvestments 81,542 53,020 53,020\nLong-term accounts receivable-other, net 95,797 99,299 101,898\nRight-of-use asset - operating lease, net 2,089,402 1,955,354 1,824,095\nLease and guarantee deposits 848,691 895,344 868,159\nDeferred tax assets, net 101,636 ― ―\nOther assets 16,655 13,666 107,224\nTotal assets ¥ 6,849,189 ¥ 6,747,346 5,753,061\nLIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)\nCurrent liabilities:\nAccounts payable ¥ 137,697 ¥ 207,581 230,899\nAccrued expenses 1,261,909 1,383,579 865,865\nShort-term borrowings 400,000 ― ―\nCurrent portion of long-term borrowings 100,415 99,168 162,252\nAccrued income taxes 14,888 59,894 40,721\nCurrent portion of contract liability 109,307 89,008 104,182\nAdvances received 402,742 507,405 618,514\nCurrent portion of lease liability 763,422 769,769 755,219\nOther current liabilities 370,213 525,563 270,821\nTotal current liabilities 3,560,593 3,641,967 3,196,473\nBorrowings - net of current portion 1,050,802 1,149,769 746,588\nDeposit received 261,922 304,577 328,962\nContract liability - net of current portion 71,134 156,431 239,067\nLease liability - net of current portion 1,334,630 1,212,629 1,128,737\nAsset retirement obligation 344,346 310,929 296,401\nOther liabilities 9,801 30,422 25,176\nTotal liabilities 6,633,228 6,806,724 5,961,404\nCOMMITMENTS AND CONTINGENCIES (NOTE 17)\nSHAREHOLDERS’ EQUITY (DEFICIT):\nCommon stock, no par value; 19,899,999 shares authorized; 4,975,000 shares issued and 19,900 1,223,134 1,223,134\nClass A common stock, no par value; 1 share authorized; 1 share issued and 1 share 100 100 100\nTreasury stock, at cost- 92,500 common shares at December 31, 2023 and 2022 -3,000 -3,000 -3,000\nAdditional paid-in capital 113,602 1,265,456 1,265,456\nRetained earnings (accumulated deficit) 80,277 -2,545,068 -2,694,033\nTotal 'equity (deficit) attributable to shareholders of the Company 210,879 -59,378 -208,343\nNoncontrolling interests 5,082 －\nTotal equity (deficit) 215,961 -59,378 -208,343\nTotal liabilities and shareholders' equity (deficit) 6,849,189 6,747,346 5,753,061"
        },
        {
          "title": "Cashflow Statement (2023) Excel",
          "url": "https://medirom.co.jp/upload/tenant_1/MRMCashFlow2023.xlsx",
          "content": null
        },
        {
          "title": "Cashflow Statement (2023) PDF",
          "url": "https://medirom.co.jp/upload/tenant_1/MRMCashFlow2023.pdf",
          "content": "FS_CashFlows\nYears Ended December 31,\n2023 2022 2021\nCash flows from operating activities:\nNet income (loss) ¥ 115,049 ¥ 148,965 ¥ -990,731\nAdjustments to reconcile net income (loss) to net cash used in operating\nactivities:\nDepreciation and amortization 252,595 184,056 126,243\nLosses on sales of directly-owned salons to franchisees ― ― 2,692\nGain from sales of directly-owned salons -1,244,240 -858,548 -541,472\nBad debt 1,958 -36,355 28,808\nStock-based compensation ― ― 196,853\nForeign currency exchange (gain) loss -17,402 ― ―\n(Gains) losses on disposal of property and equipment, net, other intangible\n-2,648 12,908 3,614\nassets, net and goodwill\nImpairment loss on long-lived assets ― ― 63,211\nDeferred income taxes, net -101,636 ― 551,483\nOther non-cash losses – net 45,718 ― 819\nChanges in operating assets and liabilities:\nAccounts receivable-trade, net 580,681 -222,384 -37,024\nAccounts receivable-other, net 43,382 -210,476 -87,148\nInventories -25,873 -95,406 -2,441\nPrepaid expenses and other current assets -530 -181,477 -74,799\nLease and guarantee deposits 46,652 -27,185 -70,662\nAccounts payable -69,884 -23,318 58,437\nAccrued expenses 97,045 517,714 195,541\nAccrued income taxes -45,006 19,173 -2,897\nContract liability -64,999 -82,636 -162,793\nAdvances received -104,663 -111,109 96,198\nOther current liabilities -77,447 254,742 130,110\nDeposit received -42,656 -24,411 -46,501\nOther assets and other liabilities – net -17,833 50,050 5,228\nNet cash used in operating activities -631,737 -685,697 -557,231\nCash flows from investing activities:\nPurchases of time deposits ― ― -26,402\nProceeds from maturities of time deposits ― ― 6,000\nAcquisition of investments -3,094 ― -52,520\nAcquisition of property and equipment -135,840 -120,740 -95,651\nProceeds from sale of property and equipment ― 40,620 ―\nAcquisition of intangible assets -786,178 -45,761 -18,127\nProceeds from sale of salons 584,768 851,719 430,000\nAcquisition of businesses – net of cash acquired ― -148,000 -375,757\nPayment received on short-term loans receivable 113 ― 450\nPayment received on long-term accounts receivable-other, net 11,655 2,599 9,488\nProceeds from insurance cancellations ― ― 38,583\nNet cash (used in) provided by investing activities ¥ -328,576 ¥ 580,437 ¥ -83,936"
        },
        {
          "title": "Income Statement 1st Half FY2020-FY2023 Excel",
          "url": "https://medirom.co.jp/upload/tenant_1/Income_Statement_1st_Half_FY2020_FY2021_2022_2023_YK.xlsx",
          "content": null
        },
        {
          "title": "Income Statement 1st Half FY2020-FY2023 PDF",
          "url": "https://medirom.co.jp/upload/tenant_1/Income_Statement_1st_Half_FY2020_FY2021_2022_2023_YK.pdf",
          "content": "MEDIROM HEALTHCARE TECHNOLOGIES INC.\nCONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME (UNAUDITED)\nFOR THE SIX MONTHS ENDED JUNE 30, 2023, 2022, 2021 AND 2020\n(Yen in thousands, except share and per share data)\nSix Months Ended June30,\nRevenue 2023 2022 2021 2020\nRevenue from directly-operated salons 2,690,467 2,524,149 1,421,413 751,267\nFranchise revenue 489,593 580,859 689,148 593,236\nOther revenues 62,730 42,037 16,918 11,774\nTotal revenues 3,242,790 3,147,045 2,127,479 1,356,277\nCost of revenues and operating expenses:\nCost of revenue from directly-operated salons 2,238,417 2,001,921 1,415,685 866,297\nCost of franchise revenue 269,229 279,223 335,458 394,906\nCost of other revenues 56,185 50,106 17,764 8,017\nSelling, general and administrative expenses 989,222 969,503 840,760 521,364\nImpairment loss on long-lived assets — 1,173 — —\nTotal cost of revenues and operating expenses 3,553,053 3,301,926 2,609,667 1,790,584\nOperating (loss) income (310,263) (154,881) (482,188) (434,307)\nOther income (expense):\nDividend income 2 2 2 2\nInterest income 1 357 506 674\nInterest expense (16,859) (5,707) (6,683) (6,076)\nGain from bargain purchases ― ― 1,014 1,624\nSubsidies 10,877 18,677 1,065 12,230\nOther, net (35,089) (17,302) 19,733 1,912\nTotal other income (41,068) (3,973) 15,637 10,366\n(Loss) income before income tax expense and equity in earnings of investment (351,331) (158,854) (466,551) (423,941)\nIncome tax expense 3,735 22,687 55,291 19,030\nEquity in earnings of investment ― ― — —\nNet (loss) income (355,066) (181,541) (466,551) (442,971)\nNet (loss) earnings per share\nBasic (72.72) (37.18) (107.09) (110.12)\nDiluted (72.72) (37.18) (107.09) (110.12)\nWeighted average shares outstanding\nBasic 4,882,500 4,882,500 4,872,224 4,022,501\nDiluted 4,882,500 4,882,500 4,872,224 4,022,501"
        },
        {
          "title": "Balance Sheet 1st Half FY2020-FY2023 Excel",
          "url": "https://medirom.co.jp/upload/tenant_1/Balance_Sheet_1st_Half_FY2020_FY2021_FY2022_FY2023_YK.xlsx",
          "content": null
        },
        {
          "title": "Balance Sheet 1st Half FY2020-FY2023 PDF",
          "url": "https://medirom.co.jp/upload/tenant_1/Balance_Sheet_1st_Half_FY2020_FY2021_FY2022_FY2023_YK.pdf",
          "content": "MEDIROM HEALTHCARE TECHNOLOGIES INC. CONDENSED CONSOLIDATED BALANCE SHEETS\nAS OF JUNE 30, 2023, 2022, 2021 AND 2020 (UNAUDITED)\n(Yen in thousands, except share data)\nJune30, 2023 June30, 2022 June30, 2021 June30, 2020\nASSETS\n(Unaudited) (Unaudited) (Unaudited) (Unaudited)\nCurrent assets:\nCash and cash equivalents 117,728 100,718 354,950 225,060\nTime deposits — 26,026 — 32,520\nAccounts receivable-trade, net 591,302 374,249 89,416 144,246\nAccounts receivable-other 375,823 418,299 305,851 251,348\nDue from shareholder ― ― — 300\nInventories 193,824 29,301 10,904 5,880\nPrepaid expenses and other current assets 284,356 287,300 111,057 90,642\nTotal current assets 1,563,033 1,235,893 872,178 749,996\nNon-current assets:\nProperty and equipment, net 469,856 412,628 330,692 237,632\nGoodwill 486,998 529,939 535,246 163,008\nOther intangible assets, net 470,706 371,438 91,036 75,538\nInvestments 53,020 53,020 53,020 14,044\nLong-term accounts receivable-other, net 98,433 96,838 115,247 142,110\nRight-of-use asset−operating lease, net 2,058,796 1,881,613 1,709,722 1,631,410\nLease and guarantee deposits 853,133 864,232 784,796 684,781\nDeferred tax assets, net ― ― 613,311 211,459\nDeferred offering costs ― ― — 125,574\nOther assets 4,646 44,066 94,768 62,419\nTotal assets 6,058,621 5,489,667 5,200,016 4,097,971\nLIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)\nCurrent liabilities:\nAccounts payable 209,907 230,318 62,244 70,196\nAccrued expenses 945,514 1,051,954 814,390 437,321\nShort-term borrowings and current portion of long-term borrowings 92,350 151,641 181,884 357,285\nAccrued income taxes 24,548 46,312 13,211 20,939\nContract liability (current) 107,146 96,945 92,988 —\nAdvances received 358,613 488,056 438,482 358,296\nShort-term lease liability 746,993 732,832 702,685 683,026\nOther current liabilities 785,153 364,253 141,550 92,097\nTotal current liabilities 3,270,224 3,162,311 2,447,434 2,019,160\nNon-current liabilities:\nLong-term borrowings−net of current portion 1,104,197 697,588 573,275 380,159\nDeposit received 288,504 318,655 340,525 408,193\nLong-term contract liability - net of current portion 135,593 191,151 297,523 —\nLong-term lease liability−net of current portion 1,326,469 1,183,349 1,059,530 964,973\nAsset retirement obligation 334,826 299,546 256,967 158,680\nOther liabilities 13,252 26,951 18,693 9,719\nTotal liabilities 6,473,065 5,879,551 4,993,947 3,940,884\nSHAREHOLDERS’ EQUITY (DEFICIT):\nCommon stock, no par value;\n9,999,999 shares authorized; 4,115,000 shares issued and 4,022,500 shares\n19,900 1,223,134 1,223,134 595,000\noutstanding at June 30, 2020 and December 31, 2019\nClass A common stock, no par value;\n1 share authorized; 1 share issued and 1 share outstanding at June 30, 2020 and December 31, 100 100 100 100\n2019\nTreasury stock, at cost−92,500 common shares at June 30, 2020 and December 31, 2019 (3,000) (3,000) (3,000) (3,000)\nAdditional paid-in capital 238,185 1,265,456 1,210,907 713,267\nAccumulated deficit (669,629) (2,875,574) (2,225,072) (1,148,280)\nTotal shareholders’ equity (414,444) (389,884) 206,069 157,087\nTotal liabilities and shareholders’ equity 6,058,621 5,489,667 5,200,016 4,097,971"
        },
        {
          "title": "Cashflow Statement 1st Half FY2020-FY2023 Excel",
          "url": "https://medirom.co.jp/upload/tenant_1/Cashflow_Statement_1st_Half_FY2020_FY2021_FY2022_FY2023_YK.xlsx",
          "content": null
        },
        {
          "title": "Cashflow Statement 1st Half FY2020-FY2023 PDF",
          "url": "https://medirom.co.jp/upload/tenant_1/Cashflow_Statement_1st_Half_FY2020_FY2021_FY2022_FY2023_YK.pdf",
          "content": "MEDIROM HEALTHCARE TECHNOLOGIES INC.\nCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)\n—CONTINUED FOR THE SIX MONTHS ENDED JUNE 30, 2023, 2022, 2021 AND 2020\n(Yen in thousands)\nSix Months Ended June30,\nCash flows from operating activities: 2023 2022 2021 2020\nNet (loss) income (355,066) (181,541) (521,770) (442,971)\nAdjustments to reconcile net (loss) income to net cash (used in) provided by\noperating activities:\nDepreciation and amortization 100,849 90,418 39,631 33,105\nLosses on sales of directly-operated salons to franchisees — — 49 65\nGain from sales of directly-owned salons (350,813) (360,521) — —\nAllowance for doubtful accounts 6,735 4,998 (4,860) (5,295)\nStock-based compensation — — 148,940 —\nLosses on disposal of long-lived assets, net 2,175 9,020 1,967 26,913\nImpairment loss on long-lived assets — 1,173 — —\nGain from bargain purchases — — (1,014) (1,624)\nDeferred income tax expense — — 42,280 11,046\nOther non-cash expense (gains)−net 47,909 8,374 847 121\nChanges in operating assets and liabilities:\nAccounts receivable-trade, net (87,134) 50,484 72,839 192,093\nAccounts receivable-other 282,116 124,578 108,981 89,518\nInventories (79,714) (10,598) (50) (369)\nPrepaid expenses and other current assets 26,360 (92,103) (35,395) (37,422)\nLease and guarantee deposits 42,211 3,927 (16,902) 84,323\nAccounts payable 2,326 (581) (8,303) (52,394)\nAccrued expenses (382,096) 197,339 106,131 (62,280)\nAccrued income taxes (35,347) 5,591 (30,267) 3,105\nContract liability (2,700) (55,153) (115,531) —\nAdvances received (148,792) (172,313) (96,535) (124,828)\nOther current liabilities 337,493 106,099 597 (23,476)\nDeposit received (16,073) (10,308) (34,938) (66,195)\nOther assets and other liabilities−net (476) (5,266) (4,963) 1,704\nNet cash (used in) provided by operating activities (610,037) (286,383) (348,266) (374,861)\nCash flows from investing activities:\nPurchases of time deposits — (13,201) (13,201) (13,500)\nProceeds from maturities of time deposits — — — 10,000\nProceeds from sale of affiliated company securities — — — 50,000\nAcquisition of investment securities — — (52,520) —\nAcquisition of property and equipment (56,241) (40,366) (41,370) (70,803)\nProceeds from sale of property and equipment — — — 3,227\nCost additions to internal use software (83,618) (32,042) (7,631) (9,492)\nProceeds from sale of salons 315,400 309,941 — —\nAcquisition of businesses−net of cash acquired — — (300,843) (42,393)\nProceeds from due from shareholder — — — 7,966\nPayment received on short-term loans receivable 112 225 225 225\nPayment received on long-term accounts receivable-other, net — 720 5,090 7,515\nNet cash used in investing activities 175,653 225,277 (410,250) (57,255)\nCash flows from financing activities:\nProceeds from issuance of common stock for exercise of over-allotment, net of\n— — 87,642 —\nissuance costs\nProceeds from long-term borrowings — 50,000 — 330,000\nRepayment of long-term borrowings (53,342) (110,793) (155,502) (114,657)\nPayment of installment payables related to business acquisitions — — (2,520) (30,199)\nPayment of deferred offering costs — — (255,887) (41,589)\nRepayment of corporate bonds — (148,000) — —\nNet cash provided by (used in) financing activities (53,342) (208,793) (326,267) 143,555\nNet (decrease) increase in cash and cash equivalents (487,726) (269,899) (1,084,783) (288,561)\nCash and cash equivalents at beginning of period 605,454 370,617 1,439,733 513,621\nCash and cash equivalents at end of period 117,728 100,718 354,950 225,060\nSupplemental disclosure of cash flow information:\nCash paid during the period for:\nInterest 13,986 3,995 6,733 4,896\nIncome taxes 36,419 17,096 43,199 4,953\nNon-cash investing and financing activities:\nRight-of-use assets obtained in exchange for lease liabilities 459,137 468,473 490,342 189,240\nPurchases of property and equipment included in accrued expenses 19,139 19,487 2,670 9,548\nPurchases of intangible assets included in accrued expenses 13,077 4,650 2,325 —\nPayables related to acquisition of businesses included in accrued expenses — — — 60,902\nDeferred offering costs included in accrued expenses — — — 26,476\nSales of salons included in accounts receivable 102,000 241,259 — —\nReduction in common stock and additional paid-in capital 2,230,505 — — —"
        }
      ]
    },
    {
      "section_name": "IR RELEASE",
      "links": [
        {
          "title": "MEDIROM Healthcare Technologies Inc. Announces Group Reorganization of Its Subsidiaries",
          "url": "https://medirom.co.jp/en/ir/20241126/7140",
          "content": "# [![MEDIROM](/upload/tenant_1/6313cccccd817a5ab1260b5d5f8d4f16.png)![MEDIROM](/upload/tenant_1/3deb2f368a81ea61d25e1f474bf2739b.png)](/en)\n\n  * [TOP](/en)\n  * [IR](/en/ir)\n  * [IR Release](/en/ir/news)\n  * MEDIROM Healthcare Technologies Inc. Announces Group Reorganization of Its Subsidiaries\n\n\n\n### IR RELEASE\n\n![IR RELEASE](/upload/tenant_1/53f72c214a7aa1248a7ecfa8299d5378.png)\n\n2024/11/26\n\nMEDIROM Healthcare Technologies Inc. Announces Group Reorganization of Its Subsidiaries\n\nPlease refer to the attached PDF for details.\n\n[PDF Download](/upload/tenant_1/MRM_organization_restructuring_Jan2025 .pdf)\n\n[See more IR NEWS](/en/ir/news)\n"
        },
        {
          "title": "MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)",
          "url": "https://medirom.co.jp/en/ir/20241121/7092",
          "content": "# [![MEDIROM](/upload/tenant_1/6313cccccd817a5ab1260b5d5f8d4f16.png)![MEDIROM](/upload/tenant_1/3deb2f368a81ea61d25e1f474bf2739b.png)](/en)\n\n  * [TOP](/en)\n  * [IR](/en/ir)\n  * [IR Release](/en/ir/news)\n  * MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)\n\n\n\n### IR RELEASE\n\n![IR RELEASE](/upload/tenant_1/53f72c214a7aa1248a7ecfa8299d5378.png)\n\n2024/11/21\n\nMEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)\n\nMEDIROM Healthcare Technologies Inc. announces its major Key Performance Indicators, or KPIs, updated for the month of October 2024. Please refer to the attached PDF for details.\n\n[PDF Download](/upload/tenant_1/MRM-Monthly KPI release -October 2024_ENG \\(SG 2024-11-20\\).pdf)\n\n[See more IR NEWS](/en/ir/news)\n"
        },
        {
          "title": "MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)",
          "url": "https://medirom.co.jp/en/ir/202401023/6778",
          "content": "# [![MEDIROM](/upload/tenant_1/6313cccccd817a5ab1260b5d5f8d4f16.png)![MEDIROM](/upload/tenant_1/3deb2f368a81ea61d25e1f474bf2739b.png)](/en)\n\n  * [TOP](/en)\n  * [IR](/en/ir)\n  * [IR Release](/en/ir/news)\n  * MEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)\n\n\n\n### IR RELEASE\n\n![IR RELEASE](/upload/tenant_1/53f72c214a7aa1248a7ecfa8299d5378.png)\n\n2024/10/24\n\nMEDIROM Healthcare Technologies Inc., Announces its latest Key Performance Indicators (KPIs)\n\nMEDIROM Healthcare Technologies Inc. announces its major Key Performance Indicators, or KPIs, updated for the month of September 2024. Please refer to the attached PDF for details.\n\n[PDF Download](/upload/tenant_1/MRM-Monthly KPI release -September 2024_ENG.pdf)\n\n[See more IR NEWS](/en/ir/news)\n"
        },
        {
          "title": "ELEMATEC CORPORATION FORMS A BUSINESS ALLIANCE WITH AND STRATEGIC INVESTMENT IN MEDIROM HEALTHCARE TECHNOLOGIES’ MOTHER LABS SUBSIDIARY",
          "url": "https://medirom.co.jp/en/ir/202410015/6702",
          "content": "# [![MEDIROM](/upload/tenant_1/6313cccccd817a5ab1260b5d5f8d4f16.png)![MEDIROM](/upload/tenant_1/3deb2f368a81ea61d25e1f474bf2739b.png)](/en)\n\n  * [TOP](/en)\n  * [IR](/en/ir)\n  * [IR Release](/en/ir/news)\n  * ELEMATEC CORPORATION FORMS A BUSINESS ALLIANCE WITH AND STRATEGIC INVESTMENT IN MEDIROM HEALTHCARE TECHNOLOGIES’ MOTHER LABS SUBSIDIARY\n\n\n\n### IR RELEASE\n\n![IR RELEASE](/upload/tenant_1/53f72c214a7aa1248a7ecfa8299d5378.png)\n\n2024/10/15\n\nELEMATEC CORPORATION FORMS A BUSINESS ALLIANCE WITH AND STRATEGIC INVESTMENT IN MEDIROM HEALTHCARE TECHNOLOGIES’ MOTHER LABS SUBSIDIARY\n\nPlease refer to the attached PDF for details.\n\n[PDF Download](/upload/tenant_1/EN_MRM_ELEMATEC20241015.pdf)\n\n[See more IR NEWS](/en/ir/news)\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "SEC Filings",
          "url": "https://www.sec.gov/edgar/browse/?CIK=1819704&owner=exclude",
          "content": "![Hidden document icon](images/small-doc.png)\n\n[Home](/index.htm) » [Company Search](/edgar/searchedgar/companysearch.html)\n\n###  Medirom Healthcare Technologies Inc. MRM on Nasdaq\n\n##### This company's Exchange Act registration has been revoked\n\n##### This company's Exchange Act registration as a Municipal Advisor has been revoked\n\n##### This company's Exchange Act registration as a Municipal Advisor has been cancelled\n\nInvestor toolkit: \n\n[On](#)\n\n#####  [[+]](#) Company Information \n\n**CIK:** 1819704\n\n**EIN:**\n\n**SIC:**[7200](/cgi-bin/browse-edgar?action=getcompany&SIC=7200) - Services-Personal Services\n\n(CF Office: 07 Trade & Services) \n\n**State location:**[Japan](/cgi-bin/browse-edgar?action=getcompany&State=M0)\n\n**State of incorporation:** Japan\n\n**Fiscal year end:** December 31\n\n**Business address:** 2-3-1 DAIBA, MINATO-KU, TOKYO, Japan, 135-0091 _Phone:_ 81-3-6721-7364\n\n**Mailing address:** 2-3-1 DAIBA, MINATO-KU, TOKYO, Japan, 135-0091\n\n**Category:**\n\n**Filings:** 137 EDGAR filings since September 11, 2020\n\nGet insider transactions for this **issuer**\n\nGet insider transactions for this **reporting owner**\n\nList all funds and classes/contracts for \n\n#####  Latest Filings (excluding insider transactions)\n\n  * [December 2, 2024 - F-1/A: Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/1819704/000110465924124232/tm2422156-8_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/1819704/000110465924124232/0001104659-24-124232-index.htm)Click to Open filing\n  * [November 21, 2024 - 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/1819704/000155837024015878/tmb-20241121x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/1819704/000155837024015878/0001558370-24-015878-index.htm)Click to Open filing\n  * [November 8, 2024 - 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/1819704/000155837024014918/tmb-20241107x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/1819704/000155837024014918/0001558370-24-014918-index.htm)Click to Open filing\n  * [November 8, 2024 - 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/1819704/000155837024014916/tmb-20241107x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/1819704/000155837024014916/0001558370-24-014916-index.htm)Click to Open filing\n  * [November 7, 2024 - F-1/A: Registration statement for certain foreign private issuers - _amendment_ Open document](/ix?doc=/Archives/edgar/data/1819704/000110465924115389/mrm-20240630xf1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/1819704/000110465924115389/0001104659-24-115389-index.htm)Click to Open filing\n\n\n\nView filings Hide filings\n\n#####  Selected Filings \n\n##### [[+]](#) 8-K (current reports)\n\nNo 8-K filing data for this company in last 110 days \n\nView all 8-Ks How to read an 8-K\n\n##### [[+]](#) 10-K (annual reports) and 10-Q (quarterly reports)\n\nNo 10-K/10-Q filings for this company in last 365 days \n\nView all 10-Ks and 10-Qs How to read a 10-K/10-Q\n\n##### [[+]](#) Proxy (annual meeting) and information statements\n\nNo Proxy filings for this company in last 365 days \n\nView all proxy and information statements Learn about proxy statements\n\n##### [[+]](#) Ownership disclosures\n\n  * Insider transactions \n\nNo insider transaction filings for this company in last 365 days \n\n\nView all insider transactions Learn about insider transactions\n\n  * Beneficial ownership (Schedule 13D and 13G) \n\nNo beneficial ownership filings for this company in last 365 days \n\n\nView all beneficial ownership Learn about Schedules 13D/G\n\n##### Filings\n\nExclude insider transactions\n\n[All](#) [Exclude insider transactions](#) [Current reports](#) [Annual & quarterly reports](#) [Proxy statements](#) [Insider transactions](#) [Beneficial ownership](#) [Proxy voting records](#) [Shareholder reports](#) [Statutory prospectuses](#) [Summary prospectuses](#)\n\nSearch table Search table From Date (yyyy-mm-dd) From Date (yyyy-mm-dd) To Date (yyyy-mm-dd) To Date (yyyy-mm-dd) Clear Learn about insider transactions\n\nClear\n\nKeywords: Search text in documents\n\nShow columns:\n\nForm type Click to toggle column visibility\n\nForm description Click to toggle column visibility\n\nFiling date Click to toggle column visibility\n\nReporting date Click to toggle column visibility\n\nAct Click to toggle column visibility\n\nFilm number Click to toggle column visibility\n\nFile number Click to toggle column visibility\n\nAccession number Click to toggle column visibility\n\nSize Click to toggle column visibility\n\n...Grid Refreshed \n\nCopy to clipboard CSV Excel Print ![RSS Feed Images](./images/rss-feed-icon-14x14.png) RSS feed\n\nSearch:\n\nForm type| Form description| Filing date| Reporting date  \n---|---|---|---  \n  \nForm type| Form description| Filing date| Reporting date  \n---|---|---|---  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465924124232/tm2422156-8_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465924124232/0001104659-24-124232-index.htm)Click to Open filing| 2024-12-02  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024015878/tmb-20241121x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024015878/0001558370-24-015878-index.htm)Click to Open filing| 2024-11-21| [2024-11-21View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024014918/tmb-20241107x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024014918/0001558370-24-014918-index.htm)Click to Open filing| 2024-11-08| [2024-11-07View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024014916/tmb-20241107x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024014916/0001558370-24-014916-index.htm)Click to Open filing| 2024-11-08| [2024-11-07View all with same reporting date](#)  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/ix?doc=/Archives/edgar/data/0001819704/000110465924115389/mrm-20240630xf1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465924115389/0001104659-24-115389-index.htm)Click to Open filing| 2024-11-07  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024013556/tmb-20241024x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024013556/0001558370-24-013556-index.htm)Click to Open filing| 2024-10-24| [2024-10-24View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024013267/tmb-20241015x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024013267/0001558370-24-013267-index.htm)Click to Open filing| 2024-10-15| [2024-10-15View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024013248/tmb-20241008x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024013248/0001558370-24-013248-index.htm)Click to Open filing| 2024-10-11| [2024-10-08View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024012975/tmb-20240924x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024012975/0001558370-24-012975-index.htm)Click to Open filing| 2024-09-24| [2024-09-24View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024012479/tmb-20240827x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024012479/0001558370-24-012479-index.htm)Click to Open filing| 2024-08-27| [2024-08-27View all with same reporting date](#)  \nF-1| [Registration statement for certain foreign private issuersOpen document](/ix?doc=/Archives/edgar/data/0001819704/000110465924092501/mrm-20231231xf1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465924092501/0001104659-24-092501-index.htm)Click to Open filing| 2024-08-23  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024012467/tmb-20240823x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024012467/0001558370-24-012467-index.htm)Click to Open filing| 2024-08-23| [2024-08-23View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024009954/tmb-20240723x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024009954/0001558370-24-009954-index.htm)Click to Open filing| 2024-07-23| [2024-07-23View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024009741/tmb-20240710x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024009741/0001558370-24-009741-index.htm)Click to Open filing| 2024-07-10| [2024-07-10View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024009458/tmb-20240625x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024009458/0001558370-24-009458-index.htm)Click to Open filing| 2024-06-25| [2024-06-25View all with same reporting date](#)  \n20-F| [Annual and transition report of foreign private issuers [Sections 13 or 15(d)]Open document](/ix?doc=/Archives/edgar/data/0001819704/000155837024009293/mrm-20231231x20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024009293/0001558370-24-009293-index.htm)Click to Open filing| 2024-06-18| [2023-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024008509/tmb-20240521x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024008509/0001558370-24-008509-index.htm)Click to Open filing| 2024-05-21| [2024-05-21View all with same reporting date](#)  \nNT 20-F| [Notification of inability to timely file Form 20-FOpen document](/Archives/edgar/data/0001819704/000110465924054394/tm2412809d1_nt20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465924054394/0001104659-24-054394-index.htm)Click to Open filing| 2024-04-30| [2023-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024005523/tmb-20240424x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024005523/0001558370-24-005523-index.htm)Click to Open filing| 2024-04-24| [2024-04-24View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024004608/tmb-20240402x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024004608/0001558370-24-004608-index.htm)Click to Open filing| 2024-04-02| [2024-04-02View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024004318/tmb-20240329x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024004318/0001558370-24-004318-index.htm)Click to Open filing| 2024-03-29| [2024-03-29View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024003661/tmb-20240321x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024003661/0001558370-24-003661-index.htm)Click to Open filing| 2024-03-21| [2024-03-21View all with same reporting date](#)  \n6-K/A| [Report of foreign issuer [Rules 13a-16 and 15d-16] - _amendment_ Open document](/Archives/edgar/data/0001819704/000155837024003294/tmb-20240311x6ka.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024003294/0001558370-24-003294-index.htm)Click to Open filing| 2024-03-15| [2024-03-11View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024002919/tmb-20240311x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024002919/0001558370-24-002919-index.htm)Click to Open filing [Amendments](#)| 2024-03-11| [2024-03-11View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024001536/tmb-20240222x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024001536/0001558370-24-001536-index.htm)Click to Open filing| 2024-02-22| [2024-02-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000155837024000548/tmb-20240125x6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837024000548/0001558370-24-000548-index.htm)Click to Open filing| 2024-01-25| [2024-01-25View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923130467/tm2333787d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923130467/0001104659-23-130467-index.htm)Click to Open filing| 2023-12-29| [2023-12-29View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923128520/tm2333593d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923128520/0001104659-23-128520-index.htm)Click to Open filing| 2023-12-22| [2023-12-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923120975/tm2331278d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923120975/0001104659-23-120975-index.htm)Click to Open filing| 2023-11-24| [2023-11-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923111254/tm2329089d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923111254/0001104659-23-111254-index.htm)Click to Open filing| 2023-10-25| [2023-10-25View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923110969/tm2328985d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923110969/0001104659-23-110969-index.htm)Click to Open filing| 2023-10-24| [2023-10-24View all with same reporting date](#)  \nS-8| [Securities to be offered to employees in employee benefit plansOpen document](/Archives/edgar/data/0001819704/000110465923106004/tm2326708d1_s8.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923106004/0001104659-23-106004-index.htm)Click to Open filing| 2023-10-03  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923102299/tm2326478d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923102299/0001104659-23-102299-index.htm)Click to Open filing| 2023-09-20| [2023-09-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923094239/tm2319909d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923094239/0001104659-23-094239-index.htm)Click to Open filing| 2023-08-22| [2023-08-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923082561/tm2321590d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923082561/0001104659-23-082561-index.htm)Click to Open filing| 2023-07-20| [2023-07-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923072877/tm2319082d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923072877/0001104659-23-072877-index.htm)Click to Open filing| 2023-06-20| [2023-06-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923067853/tm2317632d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923067853/0001104659-23-067853-index.htm)Click to Open filing| 2023-06-05| [2023-06-05View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923067271/tm2317632d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923067271/0001104659-23-067271-index.htm)Click to Open filing| 2023-06-02| [2023-06-02View all with same reporting date](#)  \n20-F| [Annual and transition report of foreign private issuers [Sections 13 or 15(d)]Open document](/ix?doc=/Archives/edgar/data/0001819704/000155837023010611/mrm-20221231x20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837023010611/0001558370-23-010611-index.htm)Click to Open filing| 2023-05-30| [2022-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923063800/tm2316269d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923063800/0001104659-23-063800-index.htm)Click to Open filing| 2023-05-24| [2023-05-24View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923063150/tm2316269d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923063150/0001104659-23-063150-index.htm)Click to Open filing| 2023-05-22| [2023-05-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923053595/tm2314203d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923053595/0001104659-23-053595-index.htm)Click to Open filing| 2023-05-01| [2023-04-28View all with same reporting date](#)  \nNT 20-F| [Notification of inability to timely file Form 20-FOpen document](/Archives/edgar/data/0001819704/000110465923052987/tm2313930d1_20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923052987/0001104659-23-052987-index.htm)Click to Open filing| 2023-04-28| [2022-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923047741/tm2313276d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923047741/0001104659-23-047741-index.htm)Click to Open filing| 2023-04-20| [2023-04-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923039646/tm2310986d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923039646/0001104659-23-039646-index.htm)Click to Open filing| 2023-03-31| [2023-03-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923036891/tm2310596d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923036891/0001104659-23-036891-index.htm)Click to Open filing| 2023-03-27| [2023-03-27View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923033338/tm239526d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923033338/0001104659-23-033338-index.htm)Click to Open filing| 2023-03-16| [2023-03-16View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923033076/tm239526d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923033076/0001104659-23-033076-index.htm)Click to Open filing| 2023-03-16| [2023-03-16View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923024080/tm237363d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923024080/0001104659-23-024080-index.htm)Click to Open filing| 2023-02-22| [2023-02-22View all with same reporting date](#)  \nSC 13D| [General Statement of Acquisition of Beneficial OwnershipOpen document](/Archives/edgar/data/0001819704/000110465923006544/tm234310d1_sc13d.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923006544/0001104659-23-006544-index.htm)Click to Open filing| 2023-01-25  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923005044/tm233747d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923005044/0001104659-23-005044-index.htm)Click to Open filing| 2023-01-19| [2023-01-19View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465923004608/tm233747d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923004608/0001104659-23-004608-index.htm)Click to Open filing| 2023-01-18| [2023-01-18View all with same reporting date](#)  \nRW| [Registration Withdrawal RequestOpen document](/Archives/edgar/data/0001819704/000110465923003042/tm233117d1_rw.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465923003042/0001104659-23-003042-index.htm)Click to Open filing| 2023-01-11  \nSC 13D| [General Statement of Acquisition of Beneficial OwnershipOpen document](/Archives/edgar/data/0001819704/000121390023001206/ea171283-sc13dkufu_medirom.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000121390023001206/0001213900-23-001206-index.htm)Click to Open filing| 2023-01-06  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922131338/tm2233472d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922131338/0001104659-22-131338-index.htm)Click to Open filing| 2022-12-30| [2022-12-30View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922130638/tm2233500d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922130638/0001104659-22-130638-index.htm)Click to Open filing| 2022-12-29| [2022-12-28View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922129983/tm2233472d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922129983/0001104659-22-129983-index.htm)Click to Open filing| 2022-12-27| [2022-12-27View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922128876/tm2233119d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922128876/0001104659-22-128876-index.htm)Click to Open filing| 2022-12-21| [2022-12-21View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922128632/tm2233081d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922128632/0001104659-22-128632-index.htm)Click to Open filing| 2022-12-20| [2022-12-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922127803/tm2232532d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922127803/0001104659-22-127803-index.htm)Click to Open filing| 2022-12-16| [2022-12-16View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922125855/tm2232319d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922125855/0001104659-22-125855-index.htm)Click to Open filing| 2022-12-09| [2022-12-09View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922125636/tm2232319d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922125636/0001104659-22-125636-index.htm)Click to Open filing| 2022-12-09| [2022-12-09View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922121517/tm2231178d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922121517/0001104659-22-121517-index.htm)Click to Open filing| 2022-11-23| [2022-11-23View all with same reporting date](#)  \n20-F| [Annual and transition report of foreign private issuers [Sections 13 or 15(d)]Open document](/ix?doc=/Archives/edgar/data/0001819704/000155837022017729/mrm-20211231x20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837022017729/0001558370-22-017729-index.htm)Click to Open filing| 2022-11-14| [2021-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922110298/tm2228549d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922110298/0001104659-22-110298-index.htm)Click to Open filing| 2022-10-20| [2022-10-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922101567/tm2226118d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922101567/0001104659-22-101567-index.htm)Click to Open filing| 2022-09-20| [2022-09-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922093364/tm2224259d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922093364/0001104659-22-093364-index.htm)Click to Open filing| 2022-08-22| [2022-08-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922082004/tm2221532d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922082004/0001104659-22-082004-index.htm)Click to Open filing| 2022-07-22| [2022-07-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922076838/tm2220112d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922076838/0001104659-22-076838-index.htm)Click to Open filing| 2022-07-01| [2022-07-01View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922072775/tm2218952d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922072775/0001104659-22-072775-index.htm)Click to Open filing| 2022-06-21| [2022-06-21View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922062909/tm2216036d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922062909/0001104659-22-062909-index.htm)Click to Open filing| 2022-05-19| [2022-05-19View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922062452/tm2215806d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922062452/0001104659-22-062452-index.htm)Click to Open filing| 2022-05-18| [2022-05-18View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922056997/tm2214721d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922056997/0001104659-22-056997-index.htm)Click to Open filing| 2022-05-06| [2022-05-06View all with same reporting date](#)  \nNT 20-F| [Notification of inability to timely file Form 20-FOpen document](/Archives/edgar/data/0001819704/000110465922052259/tm2213847d1_nt20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922052259/0001104659-22-052259-index.htm)Click to Open filing| 2022-04-28| [2021-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922048964/tm2213353d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922048964/0001104659-22-048964-index.htm)Click to Open filing| 2022-04-22| [2022-04-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922046866/tm2212924d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922046866/0001104659-22-046866-index.htm)Click to Open filing| 2022-04-18| [2022-04-18View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922040130/tm2210851d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922040130/0001104659-22-040130-index.htm)Click to Open filing| 2022-03-30| [2022-03-30View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922035549/tm229622d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922035549/0001104659-22-035549-index.htm)Click to Open filing| 2022-03-18| [2022-03-18View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922033328/tm228950d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922033328/0001104659-22-033328-index.htm)Click to Open filing| 2022-03-14| [2022-03-14View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922030628/tm2116867d17_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922030628/0001104659-22-030628-index.htm)Click to Open filing| 2022-03-04| [2022-03-04View all with same reporting date](#)  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465922026477/tm2116867-7_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922026477/0001104659-22-026477-index.htm)Click to Open filing| 2022-02-24  \nF-1| [Registration statement for certain foreign private issuersOpen document](/ix?doc=/Archives/edgar/data/0001819704/000110465922024014/mrm-20220107xf1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922024014/0001104659-22-024014-index.htm)Click to Open filing| 2022-02-16  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922006896/tm224126d2_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922006896/0001104659-22-006896-index.htm)Click to Open filing| 2022-01-24| [2022-01-24View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465922006461/tm224126d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465922006461/0001104659-22-006461-index.htm)Click to Open filing| 2022-01-21| [2022-01-21View all with same reporting date](#)  \nDRS| [Draft Registration StatementOpen document](/Archives/edgar/data/0001819704/000110465921154386/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921154386/0001104659-21-154386-index.htm)Click to Open filing| 2021-12-30  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921152161/tm2135983d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921152161/0001104659-21-152161-index.htm)Click to Open filing| 2021-12-21| [2021-12-21View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921149082/tm2135205d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921149082/0001104659-21-149082-index.htm)Click to Open filing| 2021-12-13| [2021-12-13View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921141862/tm2133503d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921141862/0001104659-21-141862-index.htm)Click to Open filing| 2021-11-19| [2021-11-19View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921135697/tm2132199d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921135697/0001104659-21-135697-index.htm)Click to Open filing| 2021-11-08| [2021-11-08View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921133668/tm2131647d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921133668/0001104659-21-133668-index.htm)Click to Open filing| 2021-11-03| [2021-11-03View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921127878/tm2130538d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921127878/0001104659-21-127878-index.htm)Click to Open filing| 2021-10-20| [2021-10-20View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921119312/tm2128391d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921119312/0001104659-21-119312-index.htm)Click to Open filing| 2021-09-24| [2021-09-24View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921118324/tm2128204d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921118324/0001104659-21-118324-index.htm)Click to Open filing| 2021-09-22| [2021-09-22View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921107548/tm2125385d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921107548/0001104659-21-107548-index.htm)Click to Open filing| 2021-08-19| [2021-08-19View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921093271/tm2122286d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921093271/0001104659-21-093271-index.htm)Click to Open filing| 2021-07-19| [2021-07-19View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921083800/tm2120063d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921083800/0001104659-21-083800-index.htm)Click to Open filing| 2021-06-22| [2021-06-18View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921078002/tm2119086d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921078002/0001104659-21-078002-index.htm)Click to Open filing| 2021-06-08| [2021-06-08View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921070461/a21-17234_16k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921070461/0001104659-21-070461-index.htm)Click to Open filing| 2021-05-21| [2021-05-21View all with same reporting date](#)  \n6-K/A| [Report of foreign issuer [Rules 13a-16 and 15d-16] - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465921069020/tm2116802d1_6ka.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921069020/0001104659-21-069020-index.htm)Click to Open filing| 2021-05-19| [2021-05-17View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921068130/a21-16336_26k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921068130/0001104659-21-068130-index.htm)Click to Open filing [Amendments](#)| 2021-05-17| [2021-05-17View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921067470/a21-16336_16k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921067470/0001104659-21-067470-index.htm)Click to Open filing [Amendments](#)| 2021-05-17| [2021-05-17View all with same reporting date](#)  \n20-F| [Annual and transition report of foreign private issuers [Sections 13 or 15(d)]Open document](/Archives/edgar/data/0001819704/000155837021007318/mrm-20201231x20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000155837021007318/0001558370-21-007318-index.htm)Click to Open filing| 2021-05-17| [2020-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921059037/a21-14345_16k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921059037/0001104659-21-059037-index.htm)Click to Open filing| 2021-04-30| [2021-04-30View all with same reporting date](#)  \nNT 20-F| [Notification of inability to timely file Form 20-FOpen document](/Archives/edgar/data/0001819704/000110465921058974/a21-14354_1nt20f.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921058974/0001104659-21-058974-index.htm)Click to Open filing| 2021-04-30| [2020-12-31View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921051358/a21-13166_16k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921051358/0001104659-21-051358-index.htm)Click to Open filing| 2021-04-16| [2021-04-16View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921038332/tm219885d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921038332/0001104659-21-038332-index.htm)Click to Open filing| 2021-03-18| [2021-03-18View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921032722/tm218824d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921032722/0001104659-21-032722-index.htm)Click to Open filing| 2021-03-05| [2021-03-05View all with same reporting date](#)  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921010893/tm214694d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921010893/0001104659-21-010893-index.htm)Click to Open filing| 2021-02-02| [2021-02-02View all with same reporting date](#)  \nSC 13G| [Statement of Beneficial Ownership by Certain InvestorsOpen document](/Archives/edgar/data/0001819704/000110465921004714/a21-3204_1sc13g.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921004714/0001104659-21-004714-index.htm)Click to Open filing| 2021-01-15  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465921001482/tm211829d1_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465921001482/0001104659-21-001482-index.htm)Click to Open filing| 2021-01-06| [2021-01-06View all with same reporting date](#)  \n424B4| [Prospectus [Rule 424(b)(4)]Open document](/Archives/edgar/data/0001819704/000110465920140215/tm2026644-22_424b4.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920140215/0001104659-20-140215-index.htm)Click to Open filing| 2020-12-30  \n6-K| [Report of foreign issuer [Rules 13a-16 and 15d-16]Open document](/Archives/edgar/data/0001819704/000110465920140197/tm2026644d26_6k.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920140197/0001104659-20-140197-index.htm)Click to Open filing| 2020-12-29| [2020-12-29View all with same reporting date](#)  \nSEC STAFF LETTER| [SEC Staff LetterOpen document](/Archives/edgar/data/0001819704/999999999720005907/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/999999999720005907/9999999997-20-005907-index.htm)Click to Open filing| 2020-12-28  \nEFFECT| [Notice of EffectivenessOpen document](/Archives/edgar/data/0001819704/999999999520003672/xslEFFECTX01/primary_doc.xml)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/999999999520003672/9999999995-20-003672-index.htm)Click to Open filing| 2020-12-28  \nF-1MEF| [Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]Open document](/Archives/edgar/data/0001819704/000110465920139896/a20-26644_25f1mef.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920139896/0001104659-20-139896-index.htm)Click to Open filing| 2020-12-28  \nCERT| [Form - CERTOpen document](/Archives/edgar/data/0001819704/000135445720000835/8A_Cert_MRM.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000135445720000835/0001354457-20-000835-index.htm)Click to Open filing| 2020-12-28  \nCORRESP| [CorrespondenceOpen document](/Archives/edgar/data/0001819704/000110465920138992/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920138992/0001104659-20-138992-index.htm)Click to Open filing| 2020-12-23  \nCORRESP| [CorrespondenceOpen document](/Archives/edgar/data/0001819704/000110465920138259/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920138259/0001104659-20-138259-index.htm)Click to Open filing| 2020-12-22  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465920138223/tm2026644-19_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920138223/0001104659-20-138223-index.htm)Click to Open filing| 2020-12-22  \nCORRESP| [CorrespondenceOpen document](/Archives/edgar/data/0001819704/000110465920136549/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920136549/0001104659-20-136549-index.htm)Click to Open filing| 2020-12-17  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465920136538/tm2026644-15_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920136538/0001104659-20-136538-index.htm)Click to Open filing| 2020-12-17  \nUPLOAD| [SEC-generated letterOpen document](/Archives/edgar/data/0001819704/000000000020012062/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000000000020012062/0000000000-20-012062-index.htm)Click to Open filing| 2020-12-16  \n8-A12B| [Registration of securities [Section 12(b)]Open document](/Archives/edgar/data/0001819704/000110465920135673/tm2026644d17_8a12b.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920135673/0001104659-20-135673-index.htm)Click to Open filing| 2020-12-15  \nCORRESP| [CorrespondenceOpen document](/Archives/edgar/data/0001819704/000110465920134746/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920134746/0001104659-20-134746-index.htm)Click to Open filing| 2020-12-11  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465920134744/tm2026644-12_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920134744/0001104659-20-134744-index.htm)Click to Open filing| 2020-12-11  \nUPLOAD| [SEC-generated letterOpen document](/Archives/edgar/data/0001819704/000000000020011814/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000000000020011814/0000000000-20-011814-index.htm)Click to Open filing| 2020-12-09  \nF-1/A| [Registration statement for certain foreign private issuers - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465920132594/tm2026644-10_f1a.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920132594/0001104659-20-132594-index.htm)Click to Open filing| 2020-12-07  \nCORRESP| [CorrespondenceOpen document](/Archives/edgar/data/0001819704/000110465920127876/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920127876/0001104659-20-127876-index.htm)Click to Open filing| 2020-11-20  \nF-1| [Registration statement for certain foreign private issuersOpen document](/Archives/edgar/data/0001819704/000110465920127869/tm2026644-8_f1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920127869/0001104659-20-127869-index.htm)Click to Open filing| 2020-11-20  \nUPLOAD| [SEC-generated letterOpen document](/Archives/edgar/data/0001819704/000000000020010470/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000000000020010470/0000000000-20-010470-index.htm)Click to Open filing| 2020-11-04  \nSEC STAFF LETTER| [SEC Staff LetterOpen document](/Archives/edgar/data/0001819704/999999999720005246/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/999999999720005246/9999999997-20-005246-index.htm)Click to Open filing| 2020-11-02  \nSEC STAFF LETTER| [SEC Staff LetterOpen document](/Archives/edgar/data/0001819704/999999999720005067/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/999999999720005067/9999999997-20-005067-index.htm)Click to Open filing| 2020-10-21  \nDRSLTR| [Correspondence Related to Draft Registration StatementOpen document](/Archives/edgar/data/0001819704/000110465920116590/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920116590/0001104659-20-116590-index.htm)Click to Open filing| 2020-10-21  \nDRS/A| [Draft Registration Statement - _amendment_ Open document](/Archives/edgar/data/0001819704/000110465920116579/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920116579/0001104659-20-116579-index.htm)Click to Open filing| 2020-10-21  \nSEC STAFF LETTER| [SEC Staff LetterOpen document](/Archives/edgar/data/0001819704/999999999720004940/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/999999999720004940/9999999997-20-004940-index.htm)Click to Open filing| 2020-10-07  \nUPLOAD| [SEC-generated letterOpen document](/Archives/edgar/data/0001819704/000000000020009370/filename1.pdf)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000000000020009370/0000000000-20-009370-index.htm)Click to Open filing| 2020-10-05  \nDRS| [Draft Registration StatementOpen document](/Archives/edgar/data/0001819704/000110465920104105/filename1.htm)Click to Open document [FilingOpen filing](/Archives/edgar/data/0001819704/000110465920104105/0001104659-20-104105-index.htm)Click to Open filing| 2020-09-11  \n  \n0\n\nShowing 1 to 32 of 137 entries\n\n  * [Previous](#)\n  * [1](#)\n  * [Next](#)\n\n\n\nData source: [CIK0001819704.json](https://data.sec.gov/submissions/CIK0001819704.json)\n\nThere is no filings data for this organization \n\n#####  Investor Resources \n\n##### [How to Use EDGAR](https://www.investor.gov/introduction-investing/getting-started/researching-investments/using-edgar-research-investments)\n\nLearn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.\n\n##### [Before you Invest, Investor.gov](https://www.investor.gov/)\n\nGet answers to your investing questions from the SEC's website dedicated to retail investors\n\n![fetching data](images/loading.gif)\n\nPlease use the [Company or Person Lookup](/edgar/searchedgar/companysearch.html) to find a valid Central Index Key (CIK).\n  *[**CIK:**]: Central Index Key\n  *[**EIN:**]: Employer Identification Number\n  *[**SIC:**]: Standard Industrial Classification\n"
        }
      ]
    }
  ]
}